NB-598

CAT:
804-HY-16343-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
NB-598 - image 1

NB-598

  • Description :

    NB-598 is a potent and competitive inhibitor of squalene epoxidase (SE), and suppresses triglyceride biosynthesis through the farnesol pathway. NB-598 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    COX
  • Type :

    Reference compound
  • Related Pathways :

    Immunology/Inflammation
  • Applications :

    Metabolism-sugar/lipid metabolism
  • Field of Research :

    Metabolic Disease
  • Assay Protocol :

    https://www.medchemexpress.com/nb-598.html
  • Concentration :

    10mM
  • Purity :

    98.69
  • Solubility :

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles :

    CCN(C/C=C/C#CC(C)(C)C)CC1=CC=CC(OCC2=CC(C3=CSC=C3)=CS2)=C1
  • Molecular Formula :

    C27H31NOS2
  • Molecular Weight :

    449.67
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Xia F, et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells. Endocrinology. 2008 Oct;149 (10) :5136-45.|[2]Horie M, et al. Effects of NB-598, a potent squalene epoxidase inhibitor, on the apical membrane uptake of cholesterol and basolateral membrane secretion of lipids in Caco-2 cells. Biochem Pharmacol. 1993 Jul 20;46 (2) :297-305.|[3]Horie M, et al. An inhibitor of squalene epoxidase, NB-598, suppresses the secretion of cholesterol and triacylglycerol and simultaneously reduces apolipoprotein B in HepG2 cells. Biochim Biophys Acta. 1993 May 20;1168 (1) :45-51.
  • Shipping Conditions :

    Blue Ice
  • Storage Conditions :

    -20°C, 3 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    No Development Reported
  • Citation 01 :

    Adv Sci (Weinh) . 2023 Sep;10 (27) :e2206878.|Antioxidants (Basel) . 2024 Jun 13;13 (6) :722.|Arch Pharm (Weinheim) . 2025 Feb;358 (2) :e2400807.|Cancer Lett. 2025 May 23:217810.|Cancer Res. 2022 Sep 2;82 (17) :3032-3044.|Cell Chem Biol. 2021 Jun 17;28 (6) :866-875.e5.|Cell Metab. 2020 Apr 7;31 (4) :862-877.e14.|Genome Biol. 2016 Jun 29;17 (1) :140. |J Steroid Biochem Mol Biol. 2015 Aug;152:34-44.|Sci China Life Sci. 2022 Feb;65 (2) :341-361.|Cell Death Dis. 2021 May 13;12 (5) :482.|Cell Rep. 2020 Aug 4;32 (5) :107944.|Nat Chem Biol. 2016 Jul;12 (7) :497-503. |University of Toronto. Department of Medical Biophysics
  • CAS Number :

    [131060-14-5]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide